Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Cleveland, Ohio 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Project: Every Child for Younger Patients With Cancer
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
PHASE3INTERVENTIONAL La Jolla, California +4 more
RECRUITING
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
NAINTERVENTIONAL Long Beach, California +4 more
RECRUITING
Caris Biorepository Research Protocol
N/AOBSERVATIONAL Mobile, Alabama +4 more
RECRUITING
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
The PREDICT Registry:
N/AOBSERVATIONAL Scottsdale, Arizona +4 more
RECRUITING
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
PHASE1, PHASE2INTERVENTIONAL La Jolla, California +4 more
RECRUITING
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NAINTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
The Cancer of the Pancreas Screening-5 CAPS5)Study
PHASE3INTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
Pan Tumor Rollover Study
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
PHASE2INTERVENTIONAL Fort Myers, Florida +4 more
RECRUITING
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
PHASE1, PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
N/AOBSERVATIONAL Gilbert, Arizona +4 more
RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type